Abstract:An electro‐enhanced strategy is developed to detect low‐abundance infectious agents by a liquid‐gate graphene field‐effect transistor. The assay exhibits high accuracy (>98%) and a short response time (<60 s) in testing 402 clinical samples from tuberculosis, COVID‐19, and rhinovirus patients. This strategy solves a long‐standing dilemma of molecular diagnostic techniques in that testing accuracy and response speed undergo a trade‐off. For epidemic prevention and control, molecular diagnostic techniques such as field‐effect transistor (FET) biosensors is developed for rapid screening of infectious agents, including Mycobacterium tuberculosis, SARS‐CoV‐2, rhinovirus, and others. They obtain results within a few minutes but exhibit diminished sensitivity (<75%) in unprocessed biological samples due to insufficient recognition of low‐abundance analytes. Here, an electro‐enhanced strategy is developed for the precise detection of trace‐level infectious agents by liquid‐gate graphene field‐effect transistors (LG‐GFETs). The applied gate bias preconcentrates analytes electrostatically at the sensing interface, contributing to a 10‐fold signal enhancement and a limit of detection down to 5 × 10−16 g mL−1 MPT64 protein in serum. Of 402 participants, sensitivity in tuberculosis, COVID‐19 and human rhinovirus assays reached 97.3% (181 of 186), and specificity is 98.6% (213 of 216) with a response time of <60 s. This study solves a long‐standing dilemma that response speed and result accuracy of molecular diagnostics undergo trade‐offs in unprocessed biological samples, holding unique promise in high‐quality and population‐wide screening of infectious diseases.

Diagnostics of Tuberculosis with Single-Walled Carbon Nanotube-Based Field-Effect Transistors

Toward the Commercialization of Carbon Nanotube Field Effect Transistor Biosensors

Carbon nanotube-based thin-film resistive sensor for point-of-care screening of tuberculosis

Rapid and Sensitive Detection of Mycobacterium Tuberculosis by an Enhanced Nanobiosensor

Accurately Detecting Trace‐Level Infectious Agents by an Electro‐Enhanced Graphene Transistor

Reproducible, Accurate, and Sensitive Food Toxin On-Site Detection with Carbon Nanotube Transistor Biosensors

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.

Detecting Lyme disease using antibody-functionalized single-walled carbon nanotube transistors

Wafer-Scale Uniform Carbon Nanotube Transistors for Ultrasensitive and Label-Free Detection of Disease Biomarkers.

Miniaturized Rapid Electrochemical Immunosensor Based on Screen Printed Carbon Electrodes for Mycobacterium tuberculosis Detection

Highly electrically conductive two-dimensional Ti3C2 Mxenes-based 16S rDNA electrochemical sensor for detecting Mycobacterium tuberculosis

A Multicomponent Nucleic Acid Enzyme-Cleavable Quantum Dot Nanobeacon for Highly Sensitive Diagnosis of Tuberculosis with the Naked Eye

Carbon nanomaterials field-effect-transistor-based biosensors

Wafer-scale Biologically Sensitive Carbon Nanotube Transistors: from Fabrication to Clinical Applications

Electrical detection of hepatitis C virus RNA on single wall carbon nanotube-field effect transistors.

Addressing Signal Drift and Screening for Detection of Biomarkers with Carbon Nanotube Transistors

Carbon Nanotube Field-Effect Transistor-Based Chemical and Biological Sensors

Mass Production of Carbon Nanotube Transistor Biosensors for Point-of-Care Tests

On-Field Test of Tuberculosis Diagnosis through Exhaled Breath Analysis with a Gas Sensor Array

Sensitive and rapid detection of bacterial endotoxin with a functional carbon nanotube field-effect transistor biosensor

Picogram level electrochemical impedimetric immunosensor for monitoring Mycobacterium tuberculosis based on specific and sensitive ESAT-6 monoclonal antibody